Page 3 - Cellular Therapy Program News Today

Good news, Swifties. If you were one of the many unlucky Louisiana fans who were waitlisted in the desperate struggle this summer for tickets to one of Taylor Swifts upcoming

Faculty Position, Department of Infectious Diseases - Transplant job in Memphis, Tennessee with St. Jude Children's Research Hospital (St. Jude). Apply Today.

An Orange County chef battling a rare blood cancer found hope thanks to a donation from his daughter in France and the help of his medical team.

New research published in the New England Journal of Medicine indicates that stem cell gene therapy may offer a promising, curative treatment for the painful, inherited blood disorder sickle cell disease (SCD).

Treatment with NKX101 led to a best compositive complete response rate of 67% in patients with relapsed/refractory acute myeloid leukemia, according to updated data from a dose-expansion cohort of an ongoing phase 1 trial.

Chimeric Therapeutics Ltd (ASX:CHM), the only clinical-stage cell therapy company on the ASX, is set to begin a Phase 1B clinical trial to test the safety...

Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Chimeric Therapeutics Ltd (ASX:CHM), the only ASX clinical-stage cell therapy company, welcomes the participation of leading US centre Sarah Cannon Research...

Star pediatrician Dr. David Margolis serves up a dose of laughter to his often direly sick young patients at Children’s Hospital of Wisconsin.

Treatment with exagamglogene autotemcel conferred clinically meaningful increases in fetal hemoglobin and total hemoglobin levels among patients with beta-thalassemia and sickle cell disease, results of two pivotal studies showed. The latest follow-up data from the CLIMB THAL-111 and CLIMB-SCD-121 trials — presented at American Society for Gene & Cell Therapy Annual Meeting —